# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian epithelial cancer

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 31-40 of 535 results.
Evolution of the Therapeutic Care in Ovarian Cancer From 2011
Status: Recruiting
Last Changed: Feb 20, 2019
First Received: Sep 07, 2017
Disease(s): Ovarian Cancer
Locations: Institut de Cancérologie de l'Ouest - Paul Papin, Angers, France
Institut Bergonié, Bordeaux, France
Centre François Baclesse, Caen, France
Centre Jean Perrin, Clermont-ferrand, France
Centre Georges-François Leclerc, Dijon, France
... and 16 other locations.
Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer
Status: Recruiting
Last Changed: Jan 10, 2020
First Received: Nov 27, 2017
Disease(s): Recurrent Ovarian Carcinoma
Intervention(s): Bevacizumab, Atezolizumab, Chemotherapy, Placebos
Locations: Kreiskliniken Altötting-Burghausen, Altötting, Germany
Klinikum Augsburg, Augsburg, Germany
Hochtaunus-Kliniken, Bad Homburg, Germany
Charité - Universitätsmedizin Berlin (CVK), Berlin, Germany
Helios Klinikum Berlin-Buch, Berlin, Germany
... and 56 other locations.
Trial Comparing Niraparib-bevacizumab-TSR042 and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer
Status: Not yet recruiting
Last Changed: Jan 17, 2019
First Received: Jan 16, 2019
Disease(s): Ovarian Cancer
Intervention(s): Niraparib, Bevacizumab, TSR042, Carboplatin, Paclitaxel
Locations: NSGO, Copenhagen, Sjaelland, Denmark
Rigshospitalet, Copenhagen, Sjaelland, Denmark
Rigshospitalet, København Ø, Sjaelland, Denmark
Aalborg University Hospital, Aalborg, Denmark
Tampere University Hospital, Tampere, Finland
... and 4 other locations.
Trial of M4344 and Niraparib in Patients With Poly (ADP-ribose) Polymerase (PARP) Resistant Recurrent Ovarian Cancer
Status: Not yet recruiting
Last Changed: Jan 31, 2020
First Received: Nov 04, 2019
Disease(s): Ovarian Cancer Recurrent
Intervention(s): M4344+Niraparib, M4344+Niraparib
Locations: University of Alabama at Birmingham, Birmingham, Alabama, United States
ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK
Status: Recruiting
Last Changed: Jan 27, 2020
First Received: Sep 19, 2017
Disease(s): Ovarian Cancer
Intervention(s): VS-6063, Paclitaxel, Carboplatin
Locations: University of California San Diego, San Diego, California, United States
Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer
Status: Recruiting
Last Changed: Feb 20, 2020
First Received: May 14, 2019
Disease(s): Recurrent Ovarian Carcinoma, Platinum-resistant Ovarian Cancer
Intervention(s): ChemoID Assay, Standard Chemotherapy
Locations: Arizona Oncology, Phoenix, Arizona, United States
LSU Health Sciences Center, New Orleans, Louisiana, United States
University of Cincinnati Cancer Institute, Cincinnati, Ohio, United States
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
West Penn Hospital, Allegheny Health Network, Pittsburgh, Pennsylvania, United States
... and 3 other locations.
Clinical Pre-screening Protocol for Ovarian Cancer
Status: Recruiting
Last Changed: May 14, 2019
First Received: Mar 18, 2019
Disease(s): Ovarian Cancer
Intervention(s): Drug Response Predictor® (DRP)
Locations: Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes.
Status: Recruiting
Last Changed: Oct 22, 2019
First Received: Aug 11, 2017
Disease(s): Hereditary Breast and Ovarian Cancer, Mutation
Intervention(s): Genetic testing
Locations: Gustave Roussy, Paris, France
China Ovarian Cancer BRCA Testing Study
Status: Recruiting
Last Changed: Mar 16, 2020
First Received: Jun 29, 2017
Disease(s): Ovarian Cancer
Locations: Research Site, BeiJing, China
Research Site, Changsha, China
Research Site, Chengdu, China
Research Site, Chongqing, China
Research Site, Guangzhou, China
... and 10 other locations.
Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3)
Status: Recruiting
Last Changed: Mar 25, 2020
First Received: May 07, 2019
Disease(s): Ovarian Cancer
Intervention(s): NovoTTF-100L(O), Paclitaxel
Locations: Arizona Oncology, Tucson, Arizona, United States
Des Moines Oncology Research Association, Des Moines, Iowa, United States
Maryland Oncology Hematology, P.A., Silver Spring, Maryland, United States
Minnesota Oncology Hematology, PA, Saint Paul, Minnesota, United States
Women's Cancer Center of Nevada, Las Vegas, Nevada, United States
... and 40 other locations.